Clincosm LogoSign in Get a demo

thymus neoplasms

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
Has Results
  • Thymoma
  • Thymus Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

Esophageal Tumors, Lung Tumors, Mesothelioma Trial run by the NCI (Mithramycin)

Terminated
Has Results
  • Esophageal Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 10, 2022

Cardiotoxicity, Pulmonary Toxicity, Thymus Tumors Trial in Umeå, Stockholm, Gothenburg (Proton radiation)

Recruiting
  • Cardiotoxicity
  • +2 more
  • Proton radiation
  • Umeå, Norrland, Sweden
  • +2 more
Mar 25, 2021

Non Small Cell Lung Cancer, Small Cell Lung Cancer, Thymoma Trial in Durham (Esophageal sparing IMRT)

Completed
  • Non Small Cell Lung Cancer
  • +3 more
  • Esophageal sparing IMRT
  • Durham, North Carolina
    Duke University Medical Center
Mar 31, 2020

Thoracic OncoGeriatric Assessment (TOGA) Trials

Completed
  • Thoracic Neoplasms
  • +4 more
  • TOGA Tools
  • Madison, Wisconsin
    University of Wisconsin Hospital
Dec 12, 2019

NSCLC, Thymus Tumors Trial (3'-deoxy-3'-18F fluorothymidine (FLT), PET/CT scan)

Withdrawn
  • Carcinoma, Non-Small-Cell Lung
  • Thymus Neoplasms
  • 3'-deoxy-3'-18F fluorothymidine (FLT)
  • PET/CT scan
  • (no location specified)
Jul 3, 2018